002411SZSE

Announcement of Resolutions of the 2022 Annual General Meeting of Shareholders

Bikang Holdings··4 pages

✨ AI Summary

The 2022 Annual General Meeting of Shareholders for Yanan Bikan Pharmaceutical Co., Ltd. was held on May 25, 2023, with 415 shareholders present, representing 41.88% of voting shares. Key resolutions included the approval of the 2022 Board and Supervisory Committee reports, the annual report, financial statements, profit distribution plan, and a proposal regarding unaddressed losses. The meeting confirmed compliance with legal requirements and the validity of the voting process.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai
  1. Securities Code: 002411
    Securities Abbreviation: *ST Bikan
    Announcement Number: 2023-091

Announcement of Resolutions of the 2022 Annual General Meeting of Shareholders

Yanan Bikan Pharmaceutical Co., Ltd. and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.

Important Notice:

  1. There were no proposals rejected or modified at this shareholders' meeting;
  2. There were no changes to the resolutions from the previous shareholders' meeting;
  3. This shareholders' meeting was held combining on-site voting and online voting. Proposals were counted separately for small and medium investors (defined as shareholders other than directors, supervisors, senior management, and those holding more than 5% of shares).

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.